Bayer Execs Roth And Eckhardt On Current And Future Pharma Growth

Nubeqa, Kerendia Driving Revenue; New Launches On The Way

 
• By Mandy Jackson
  
New launches and added indications will fuel growth in 2025 as Xarelto revenue declines (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Scrip